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Summary.-Soon afteri.v. injection ofascites hepatoma cells ofrat,3types oftumour-
cell emboli were found in arterioles and capillaries of the lung. The first type had
marked aggregationofplateletsanddepositionoffibrin. Manywere seenwhentumour
cells with high thromboplastic activity (AH 130) were injected, and were often fol-
lowed by detachment and fragmentation of endothelial cells. The second type had
loosely aggregated platelets and the third type had no aggregation of platelets or
deposition of fibrin. The latter 2 types were mainly seen when the tumour cells
with low thromboplastic activity [AH 130 F(N)] were injected, and they did not
accompany severe structural changes of the endothelial cells. Tumour cell-platelet
complexes appeared to be induced by tissue thromboplastin released from tumour
cells rather than from the endothelial cells.
One to6 h after injection ofAH 130, tumour cells were found beneath the endothelial
cells detached from the basement membrane in areas with microthrombi. Breaching
of the endothelial cells with the processes of tumour cells was also seen then. Intru-
sion of the processes of tumour cells into the endothelial cells was noted in groups
injected with either AH 130 or AH 130 F(N), but not in the junctions of the endo-
thelial cells.
Metastatic foci 3 days after the injection of AH 130 were more frequent than in the
rats injected with AH 130 F(N).
These results indicate that thromboplastic activity of tumour cells might be
important in forming microthrombi in the lodgement phase and might be one of the
factors facilitating blood-borne metastasis.
AMONG the factors influencing lodge-
ment of tumour cells, their thrombo-
plastic activity (Wood, 1958), the size of
tumour-cell clumps (Allen-Liotta et at.,
1976) and deformability of tumour cells
(Sato and Suzuki, 1976) have been listed.
Fibrinogen (Hagmar, 1972; Ivarsson,
1976; Tanaka et al., 1977), platelets
(Warren and Vales, 1972; Gasic et al.,
1973) and damaged endothelium (Fidler
and Zeidman, 1972; Withers and Milas,
1973) have been added as host factors for
this event. Itisstill controversial, however,
which factor is the most important in
lodgement of tumour cells.
Mechanisms of extravasation of tumour
cells also remain obscure. Three types of
extravasation have been reported in the
literature up to the present. First is the
Marchesi-Florey type (Marchesi and
Florey, 1961) of diapedesis oftumour cells
proposed by Wood (1958) and Ludatscher
et al. (1967); second is that proposed by
Warren (1973) who showed tumour cells in
emboli progressing through damaged ves-
sel walls; and the third is described by
Chew et al. (1976) who showed multiple
breaching of endothelial cells with the
processes of arrested tumour cells.
It has so far been stressed that tumour
cells have both thromboplastic and fibrin-
olytic activities, and that these properties
vary between cell line (Kodama et al.,
1972).M. KINJO
In the present study, using ascites
hepatomas, the features of lodgement and
extravasation of tumour cells with high
and low thromboplastic activities are
illustrated by electron microscopy, and
the role of the thromboplastic activity of
tumour cells in blood-borne metastasis is
discussed.
MATERIALS AND METHODS
A closed colony strain of Donryu rats,
weighing 100-150 g, supplied from the Insti-
tute for Animal Experiment of Kyushu
University was used in the experiments.
Two lines ofascites hepatoma cells, AH 130
and AH 130 F(N), which were generously
given by Sasaki Institute in Tokyo, Japan,
and maintained in our laboratory by routine
i.p. transplantation, were used.
AH 130 is an ascitic form ofhepatoma cells
induced by aminoazo dye (Aruji, 1953) and
its high thromboplastic and high fibrinolytic
activities were confirmed by Kodama et al.
(1972). AH 130 F(N) is a free-cell type (Hiro-
no et al., 1964), and was proved to have low
thromboplastic and low fibrinolytic activities
(Kodama et al., 1972).
Tumour cells harvested 7-9 days after
implantation were washed x3 with physio-
logical saline to eliminate blood components,
suspended in physiological saline to adjust
the number to 5 x 107/ml, and tested for
viability with trypan-blue vital staining.
Viability of the inoculated tumour cells was
90-99%. Each rat was injected with 0-2 ml
of the tumour-cell suspension into the tail
vein.
For electron-microscopic observations, 24
rats were inoculated with AH 130 and a
further 24 with AH 130 F(N). All the rats
were killed at various times from 1 min to
72 h after injection of the tumour cells. The
lungs of the rats were cut into small pieces,
fixed in 3% buffered glutaraldehyde, washed
with 01M cacodylate buffer, postfixed with
1% buffered osmium tetroxide, dehydrated
by graded ethanol, embedded in Epon 812,
and cut on an LKB ultrotome. Many thick
sections were examined by light microscopy
to locate the tumour cells arrested in the
pulmonary vessels. Appropriate areas in
thick sections were then cut into thin sec-
tions, which were stained with uranyl
acetate and lead acetate.
Forty-four rats were subjected to the ex-
periment for observing microthrombi formed
around the tumour-cell emboli. Of 23 rats
injected i.v. with 107/0.2 ml of cell suspen-
sion of AH 130, 11 were killed immediately
after the injection and 12 after 1 h. For
AH 130 F(N), 21 rats were treated similarly.
The lungs were fixed with 10% aqueous
formaldehyde cut through the hilus of the
lung, processed to paraffin sections 4 ,tm
thick and stained with haematoxylin and
eosin (H. & E.). These sections were exam-
ined under the light microscope. Micro-
thrombi on the whole area of the lung were
counted.
Furthermore, to observe the effect of
thromboplastic activity of tumour cells on
blood-borne metastasis, 18 rats were divided
into 2 groups. The first group of 10 rats was
injected with 107 cells per 0-2 ml of AH 130,
and 8 rats in the second group were injected
with the same number of AH 130 F(N) cells.
All the rats were killed after 72 h. The lungs
were fixed in 10% aqueous formaldehyde,
cut through the hilus of the lung, processed
to paraffin sections and stained with H. & E.
The sections through the hilus were examined
under the light microscope. The metastatic
foci in each section, 4 ,um thick, were counted




Soon after i.v. injection of tumour cells,
tumour-cell emboli, often associated with
aggregation of platelets and/or deposition
of fibrin, were seen in arterioles and
capillaries of the lung. As shown in the
Table, these microthrombi were more
frequently found in the rats injected with






AH 130 11 27858±93-35
AH 13OF(N) 11 29-6±24*70
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FIG. 1. Tumour-cell embolus in an arteriole immediately after injection of AH 130 cells. Note
dense aggregation of platelets (P) around the tumour cells. There is a small amount of fibrin (F).
Endothelial cells are flat, but not degenerated. N: Neutrophil. T: Tumour cell. x 3500.
Within 1 h after the injection, thrombi
containing the tumour cells became com-
pact in the rats injected with AH 130,
while they remained loose in the rats
injected with AH 130 F(N). Later, the
majority of the tumour cells disappeared
from the pulmonary vessels. Forty-eight
hours after the injection, the metastatic
foci were formed mainly in alveolar septa
and periarteriolar areas in the rats
injected with AH 130, and in subpleural
and perivenular areas in the rats injected
with AH 130 F(N). Thrombi were sparse
then in small arteries, arterioles and
capillaries, in both experimental groups.
The number of metastatic foci per mm2
of lung 3 days after i.v. injection of the
tumour cells was as follows: 4-5 (±1-9)
in the rats injected with AH 130 and 2-0
(±1.2) in those injected with AH 130F(N).
The difference was statistically signifi-
cant (P<0 01).
2. Electron-microscopic observations
Electron microscopic findings at various
times after injection of the tumour cells
were as follows:
Within 10 min.-In rats injected with
AH 130, most of the tumour-cell emboli
were found in the small arteries, arterioles
and capillaries, and was closely associated
with aggregation of platelets and deposi-
tion of a small amount of fibrin (Fig. 1).
Such tumour-cell emboli accounted for
89-6% of the 87 arrested emboli observed
by electron microscopy. The majority of
the small blood vessels with tumour-cell
emboli were markedly dilated, and their
endothelial cells were flattened. However,
there was still no definite evidence of
destruction or degeneration of endothelial
cells (Fig. 1). Some tumour cells were
arrested within capillaries, irrespective of
aggregation of platelets, or deposition of
fibrin, and such emboli accounted for
10.4%.
Concerning AH 130 F(N), aggregation
of platelets was less conspicuous and less
frequent (Fig. 8). Platelets around the
tumour cells were loosely aggregated
295
IM. KINJO
FIG. 2.-Tumour-cell embolus 1 h after injection of AH 130 cells. Note detachment of endothelial
cell (E) from the basement membrane. The tumour cells (T) are present between the endothelial
cells and the basement membrane. Arrow shows a fragment of endothelial cell. Aggregated
platelets (P) show marked viscous metamorphosis. Fibrin deposition is prominent. x 4700.
together. Tumour-cell emboli with loosely
aggregated platelets accounted for 6 8%
of the 50 arrested emboli. Most of the
tumour cells were within capillaries with
no aggregation ofplatelets or deposition of
fibrin.
Fibrillar matrix was occasionally found
between the tumour cells, both AH 130
and AH 130 F(N), arrested in the pul-
monary vessels. In the periphery of this
matrix, a basement-membrane-like struc-
ture was noted (Fig. 1).
One to three hours.-In the rats injected
with AH 130, the tumour-cell emboli
became compact. Aggregated platelets
showed formation of pseudopods and
degranulation. Deposition of matured
fibrin was also observed in the emboli.
The endothelial cells were detached from
the basement membrane or subendothe-
lial layer (Fig. 2). Some tumour cells were
closely adherent to the basement mem-
brane, where fragments of endothelial
cells were occasionally found (Fig. 2).
In places, the tumour cells closely
adhered to and extended cytoplasmic
processes to the endothelial cells forming
indentation (Fig. 3 and 4). Occasionally,
cytoplasmic processes of the tumour cells
penetrated through the endothelial defects
(Fig. 5). Mitotic figures were sometimes
noted (Fig. 2).
In the rats injected with AH 130 F(N),
a few platelets loosely aggregated around
the tumour cells 1 h later. No remarkable
changes were found in the endothelial
cells, and intercellular junctions were
intact by this time. A few tumour cells
had escaped from capillaries 3 h after
injection, but most of the tumour cells
remained within arterioles and capillaries.
Six hours.-The tumour-cell emboli
associated with the degenerated platelet
mass were noted within arterioles and
capillaries intheratsinjectedwithAH 130.
In these areas, fragments of the endothe-
lial cells remained at intervals (Fig. 6).
Tumour cells adhered directly to the
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FIG. 3. Tumour-cell embolus 1 h after injection of AH 130 cells. Microvilli (MV) of the tumour cell
(T) stab the endothelial cell showing indentation of cell membrane (arrows). Endothelial cell show-
ing indentation of cell membrane (arrows). Endothelial cell is flat and shows a few pinocytic
vesicles. x 16,300
FIG. 4.- High-power view of stabbing microvilli 3 h after injection of AH 130 cells. E: Endothelial
cell. MV: Microvilli. x 38,500.
basement membrane at the site of large
endothelial defects (Fig. 6). Endothelial
cells containing a few pinocytic vesicles
were irregularly detached from the base-
ment membrane (Fig. 6). In places, cell
debris containing degenerated platelets
flowed out into the interstitium through
the endothelial defects where the basement
membrane and the elastic membrane were
also irregularly disrupted (Fig. 6).
By contrast, most of the AH 130 F(N)
tumour cells remained within capillaries.
No denudation of the endothelial cells was
found with this cell line.
Twelve hours -A small number of
tumour cell nests were found in rats
injected with AH 130. The tumour cells
proliferated in the capillary lumen, asso-
ciated with denudation of the endothelial
cells. The tumour cells were located in the
subendothelial space surrounded by the
basement membrane, and occasionally
their cytoplasmic processes extended
through the basement membrane.
On the other hand, the cells of AH 130
F(N) remained within capillaries, and any
cytoplasmic processes only extended as
far as the endothelial cells. No denudation
or fragmentation of the endothelial cells
were found.
From 24 to 48 hours. In rats injected
with AH 130, the tumour cells prolifera-
ted in the subendothelial space and
occasionally in the interstitial tissue. Some
tumour cells still lay between the endothe-
lial cells and the basement membrane.
The vascular lumina were distorted or
narrowed, but the endothelial cells ap-
peared to be intact. Some tumour cells
in the subendothelial space adhered to the
basement membrane, and the cytoplasmic
processes of the tumour cells breached the
basement membrane to protrude outside
the vessel walls (Fig. 7).
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FIG. 5. Tumour-cell embolus 1 h after injection of AH 130 cells. The tumour cell (T) extends a
cytoplasmic process (CP) outside the vessel through the endothelial defect. The degenerated endo-
thelial cell (e) has no pinocytic vesicles in its cytoplasm. E: Endothelial cell. x 1800.
In rats injected with AH 130 F(N), the
tumour cells showed extravascular growth,
forming cell nests in which capillaries
were occasionally found.
DISCUSSION
Warren and Vales (1972) proposed
2 types of adherent-tumour cell emboli,
but 3 types were noted in the present
study. The first type had dense aggrega-
tion of platelets and formation of fibrin,
and was followed by severe structural
changes of the endothelial cells. It is
noteworthy that tumour-cell emboli with
aggregation of platelets and deposition of
fibrin were more prominently and more
frequently found in rats injected with
tumour cells with high thromboplastic
activity. The second type had loosely
aggregated platelets and the third had
no aggregation ofplatelets or formation of
fibrin. The latter 2 types were mainly
observed when tumour cells with low
thromboplastic activity were injected.
Hilgard (1973) considered that embolic
tumour cells led to endothelial damage,
inducing local thrombin formation with
subsequent irreversible platelet aggrega-
tion. Platelet-aggregating activity of cer-
tain tumour cells was also recognized by
some authors (Gasic et al., 1973; Tanaka
et al., 1977). The present study shows,
however, no endothelial injury at the
embolized sites soon after injection of
tumour cells. This situation may lead to
intimate participation of the tissue
thromboplastin from tumour cells in
aggregation of platelets and formation of
fibrin, although damaged endothelial cells
may participate later in adhesion and
aggregation of platelets as described by
Fisher et al. (1967) and Hilgard (1973).
The present experiment, involving
counting the number of the metastatic
foci 3 days after the injection, appeared
2.)9 3FIG. 6.-Tumour-cell embolus within arteriole 6 h after injection of AH 130 cells. Note multiple
defects of endothelial cells. Tumour cell (T) adheres directly to the basement membrane (thick
arrows). Cell debris, including degenerated platelets flows out to the interstitium through the
endothelial defect (long arrow). Flattened endothelial cell is lifted up from the basement mem-
brane (short arrows). Platelet mass contains a small amount offibrin. x 5800.
FIG. 7. Tumour cell (T) 48 h after injection of AH 130 cells. It adheres directly to the basement
membrane (BM). The cytoplasmic processes (CP) of the tumour cell protrude into the interstitium
through the defects of basement membrane. S: Septal cell. x 8800.M. KINJO
FIG. 8. Tumour cell embolus immediately after injection of AH 130 F(N) cells. A few aggregated
platelets (P) are found around the arrested tumour cells (T). Endothelial cells show thinning of
the cytoplasm, but no degenerative changes. A, Alveolar Type II cell; S, Septal cell. x 7000.
to indicate that formation ofthe first type
of tumour-cell embolus was the most
important event closely associated with
the lodgement of the circulating tumour
cells. Warren (1973) believed that only
tumour-cell emboli with dense aggregation
of platelets and formation of fibrin could
develop into metastatic foci.
The mechanisms by which tumour cells
are extravasated are controversial. Wood
(1958) conjectured that tumour cells
penetrated the vessel walls damaged by a
histamine-like substance released from
damaged tumour cells, similar to the
manner of diapedesis of neutrophils (Mar-
chesi and Florey, 1961). On the basis of
electron-microscopic observations of pul-
monary metastases by Ludatscher et al.
(1967) it was concluded that within hours
leucocytes accumulated and penetrated
the endothelium through which tumour
cells migrated. Sindelar et al. (1975)
considered that fibrosarcoma cells could
penetrate the endothelium at the inter-
cellular junctions. Warren (1973) believed
that adherent tumour-cell emboli with
dense aggregates of platelets and deposi-
tion of fibrin were able to penetrate the
vessel walls. Recently, Chew et al. (1976)
proposed another type ofextravasation, in
which tumour cells arrested in the vessels
destroyed the endothelial cells, breached
the basement membrane by attrition, and
finally invaded the surrounding tissue
through defects of the basement mem-
brane. Thus, 3 main hypotheses have been
advanced to explain how circulating
tumour cells escape from the blood vessels.
When the tumour cells with high
thromboplastic activity were injected i.v.,
endothelial injury resulted mainly from
tumour-cell emboli with dense aggregation
of platelets and formation of fibrin, and
appeared to be a characteristic feature of
the extravasation of tumour cells. An
extension of the cytoplasmic processes of
tumour cells to the endothelial cells, and
to the subendothelial space at the site,
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with desquamation of the endothelial
cells, was occasionally found. However, it
failed to reveal how tumour cells could
penetrate the endothelium through the
intercellular junctions. Accordingly, it was
suggested that at least 2 forms of extra-
vasation, proposed by Warren (1973) and
Chew et at. (1976) respectively, could
participate, especially with tumour cells
of high thromboplastic activity. When
tumour cells had a low thromboplastic
activity, there were no severe structural
changes of the endothelial cells in the
whole process from lodgement to extra-
vasation.
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